---
DrugClass: "[[Immune Modulating Therapies]]"
SubClass: "[[Checkpoint inhibitors]]"
DrugClassAdverse: "[[Checkpoint inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Checkpoint inhibitors#Contraindications]]"
BrandName: Gilortif
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "51"
KindleLinkChap: "[Chapter 51](kindle://book?action=open&asin=B09FRF11YJ&location=30282)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: EGFR Inhibitors
---
```smiles
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Solid tumors: lung 


### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action
- [Epidermal growth factor receptor](https://go.drugbank.com/drugs/DB08916#BE0000767)
    
    Inhibitor
    
- [Receptor tyrosine-protein kinase erbB-4](https://go.drugbank.com/drugs/DB08916#BE0004772)
    
    Inhibitor

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Nausea, diarrhea, rash, [[Vision]] problems, hypomagnesia

### Interactions

`= this.ChemLink+this.file.name`

